{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T12:12:50Z","timestamp":1694261570223},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>S\u00e9zary syndrome (SS) is a peripheral T-cell lymphoma characterized by erythroderma, diffuse lymphadenopathy, and circulating neoplastic T cells, which classically show a helper T-cell immunophenotype with loss of CD7 and CD26. Flow cytometry is often used to identify and enumerate populations of S\u00e9zary cells in the peripheral blood; however, the significance and frequency of antigen shift over time is unclear. In this article, we follow the immunophenotype of the neoplastic T-cell population from 28 patients with SS across 415 flow cytometry studies. Antigen shift for each patient was assigned as none, minimal = 1\u20132 markers by 1\u00b0, moderate = up to 3 markers, or marked \u2265 4 markers. Sixty-four percent (18\/28) of patients showed antigen shift, and among those with antigen shift, the majority showed minimal (8\/18) or moderate antigen shift (7\/18) with fewer demonstrating marked shift (3\/18). Patients without antigen shift showed a trend toward improved overall survival in comparison with patients demonstrating any degree of antigen shift. Antigen shift is seen in a significant proportion of cases of SS with long-term follow-up and may be a marker of more aggressive disease.<\/jats:p>","DOI":"10.1097\/dad.0000000000001637","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:12:56Z","timestamp":1590009176000},"page":"389-396","source":"Crossref","is-referenced-by-count":0,"title":["A Long-Term Study of Persistent S\u00e9zary Syndrome: Evidence for Antigen Shift by Multiparameter Flow Cytometry and Its Significance in Overall Survival"],"prefix":"10.1097","volume":"42","author":[{"given":"Jenny C.","family":"Hoffmann","sequence":"first","affiliation":[{"name":"Fellow, Department of Pathology, Stanford University, Stanford CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Atwater","sequence":"additional","affiliation":[{"name":"Associate Professor, Department of Pathology, Stanford University, Stanford CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hong","sequence":"additional","affiliation":[{"name":"Academic Program Manager, Department of Dermatology, Stanford University, Stanford CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Kumar","sequence":"additional","affiliation":[{"name":"Resident, Department of Pathology, Stanford University, Stanford CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Khodadoust","sequence":"additional","affiliation":[{"name":"Assistant Professor, Department of Medicine and Department of Dermatology, Stanford University, Stanford CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"Professor, Department of Dermatology and Department of Medicine, Stanford University, Stanford CA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[{"name":"Associate Professor, Department of Pathology, University of California San Francisco, San Francisco CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+ CD26- subset in identification of S\u00e9zary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of immunophenotypic and molecular biomarkers for S\u00e9zary syndrome using standard operating procedures: a multicenter study of 59 patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J Invest Dermatol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ajcp\/114.3.467","article-title":"Diminished CD3 expression is useful for detecting and enumerating S\u00e9zary cells","volume":"114","author":"Edelman","year":"2000","journal-title":"Am J Clin Pathol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1309\/AJCP09OTJOYAVZZK","article-title":"Simplified flow cytometric assessment in mycosis fungoides and S\u00e9zary syndrome","volume":"136","author":"Hristov","year":"2011","journal-title":"Am J Clin Pathol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ajcp\/106.6.739","article-title":"Immunophenotypic identification of S\u00e9zary cells in peripheral blood","volume":"106","author":"Bogen","year":"1996","journal-title":"Am J Clin Pathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1309\/AJCP7QHH5XASTJPL","article-title":"Immunophenotypic stability of S\u00e9zary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy","volume":"137","author":"Vaughan","year":"2012","journal-title":"Am J Clin Pathol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cytometry in S\u00e9zary syndrome: new insignts on prognostic relevance and immunophenotypic changes during follow-up","volume":"143","author":"Novelli","year":"2015","journal-title":"Am J Clin Pathol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2017-03-772996","article-title":"Circulating and skin-derived S\u00e9zary cells: clonal but with phenotypic plasticity","volume":"130","author":"Roelens","year":"2017","journal-title":"Blood"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2012.05.010","article-title":"Can the level of CD52 epression on S\u00e9zary cells be used to predict the response of S\u00e9zary syndrome to alemtuzumab?","volume":"67","author":"Fernandes","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3109\/10428190903216770","article-title":"Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center","volume":"50","author":"Querfeld","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.jid.5700122","article-title":"CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma","volume":"126","author":"Talpur","year":"2006","journal-title":"J Invest Dermatol."},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamadermatol.2014.1629","article-title":"Brentuximab as a treatment for CD30+ mycosis fungoides and S\u00e9zary syndrome","volume":"151","author":"Mehra","year":"2015","journal-title":"JAMA Dermatol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/jid.2014.501","article-title":"Mutation in PIGA results in a CD52-negative escape variant in a S\u00e9zary syndrome patient during alemtuzumab treatment","volume":"135","author":"Halkes","year":"2015","journal-title":"J Invest Dermatol."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/cup.12797","article-title":"Loss of CD30 expression after treatment with brentuximab vedotin in anaplastic large cell lymphoma: a novel finding","volume":"43","author":"Al-Rohil","year":"2016","journal-title":"J Cutan Pathol."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/annonc\/mdw169","article-title":"Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes","volume":"27","author":"Cheah","year":"2017","journal-title":"Ann Oncol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-15-0036","article-title":"CD30 downregulation, MMAE resistance, and MDR1 upregulation are all associated with resistance to brentuximab vedotin","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cancer Ther."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis","volume":"11","author":"Kim","year":"1996","journal-title":"Arch Dermtol"},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome in patients with extracutaneous mycosis fungoides","volume":"19","author":"De Coninck","year":"2001","journal-title":"J Clin Oncol."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:14:19Z","timestamp":1694150059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001637","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}